2006
DOI: 10.1016/j.bbrc.2005.12.131
|View full text |Cite
|
Sign up to set email alerts
|

A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
45
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 39 publications
(45 citation statements)
references
References 7 publications
0
45
0
Order By: Relevance
“…13) Sansalvamide and its analogs, which were produced by organic synthesis, caused marked time-and concentration-dependent inhibition of DNA synthesis and cell proliferation of human pancreatic cancer cell lines. [15][16][17] Furthermore, sansalvamide and its analogs showed a strong cytotoxic effect against multidrug resistance (MDR) human colon cancer cell lines.…”
Section: )mentioning
confidence: 99%
See 4 more Smart Citations
“…13) Sansalvamide and its analogs, which were produced by organic synthesis, caused marked time-and concentration-dependent inhibition of DNA synthesis and cell proliferation of human pancreatic cancer cell lines. [15][16][17] Furthermore, sansalvamide and its analogs showed a strong cytotoxic effect against multidrug resistance (MDR) human colon cancer cell lines.…”
Section: )mentioning
confidence: 99%
“…[15][16][17] Furthermore, sansalvamide and its analogs showed a strong cytotoxic effect against multidrug resistance (MDR) human colon cancer cell lines. 18) These anticancer effects of sansalvamide analogs can be attributed to their inhibition of topoisomerase I, and their cytotoxicity may be mediated by this mechanism.…”
Section: )mentioning
confidence: 99%
See 3 more Smart Citations